243 filings
Page 8 of 13
8-K
9spx quub
8 May 17
CytoSorbents Announces Positive REFRESH I Trial Results
12:00am
8-K
mcirjfvkfn0 jam21
24 Apr 17
Targeting significant annual sales growth, near-term operating profitability, a U.S. pivotal trial, and greater investor awareness and ownership
12:00am
8-K
cxmz3nh2qd
11 Apr 17
Other Events
12:00am
8-K
qf6vu5dpc 7j8zy
5 Apr 17
Other Events
12:00am
8-K
4ypzkasm86c4z79cpsw
3 Apr 17
CytoSorbents Announces Proposed Offering of Common Stock
12:00am
8-K
vgce9y8
28 Mar 17
CytoSorbents Strengthens Intellectual Property Portfolio with New Patents Issued in the U.S., China, Japan, Russia, and Australia
12:00am
8-K
wzvs7r
9 Mar 17
2016 Earnings and Operating Results Conference Call
12:00am
8-K
su7p4l ovxecvm
28 Feb 17
Departure of Directors or Certain Officers
12:00am
8-K
tr1jqt8o
10 Jan 17
Other Events
12:00am
8-K
weq2pf
10 Jan 17
CytoSorbents Pre-announces Q4 2016 and Full-Year 2016 Results
12:00am
8-K
gxcdmkzr5vqbs 461dq
7 Nov 16
CytoSorb® Q3 2016 Sales Reach Record $2.14M, Doubling From a Year Ago
12:00am
8-K
yhd1c 8dl
11 Oct 16
CytoSorbents Announces Positive Top-line Safety Data from REFRESH I Cardiac Surgery Trial
12:00am
8-K
6hfmzv
11 Aug 16
CytoSorbents Achieves Fourth Consecutive Quarter of Record CytoSorb® Sales
12:00am
8-K
r334w7ss
1 Jul 16
CytoSorbents Closes $10 Million Debt Financing with Bridge Bank
12:00am
8-K
wjvn y4g1cuzw8pq5wei
10 Jun 16
Departure of Directors or Certain Officers
12:00am
8-K
9spctjwdc
8 Jun 16
Submission of Matters to a Vote of Security Holders
12:00am
8-K
zz0crb18
12 May 16
CytoSorbents Continues Strong Growth in Q1 2016
12:00am
8-K
s6qj8i0d jznm5
5 Apr 16
Other Events
12:00am
8-K
18mdi
16 Mar 16
Amendments to the Registrant's Code of Ethics, or Waiver of a Provision of the Code of Ethics
12:00am
8-K
7tr6d47 8naagxj
15 Mar 16
2015 Earnings and Operating Results Conference Call
12:00am